Insider Trading & Ownership - Nashat Amir

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Nashat Amir
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-06-22
Purchase
2022-06-24
4:27 pm
Scholar Rock Holding CorpSRRKNashat Amir
Director
1,197,992$4.9$5,870,161513,836
(Indirect
Direct)
View
2021-05-21
Sale
2021-05-25
7:20 pm
Morphic Holding Inc.MORFNashat Amir
Director
232,295$45.5$10,569,423136,691
(Indirect)
View
2020-09-18
Purchase
2020-09-22
5:10 pm
Metacrine Inc.MTCRNashat Amir
Director
10% Owner
230,000$13$2,990,000178,942
(Indirect)
View
2019-07-31
Sale
2019-08-02
4:32 pm
FATE THERAPEUTICS INCFATENashat Amir
Director
62,005$22.53$1,397,06611,034
(Indirect)
View
2019-07-26
Sale
2019-07-30
6:25 pm
FATE THERAPEUTICS INCFATENashat Amir
Director
118,333$22.51$2,663,11511,635
(Indirect)
View
2019-07-23
Sale
2019-07-25
6:24 pm
FATE THERAPEUTICS INCFATENashat Amir
Director
81,899$22.51$1,843,15112,781
(Indirect)
View
2019-07-18
Sale
2019-07-22
5:52 pm
FATE THERAPEUTICS INCFATENashat Amir
Director
71,166$22.52$1,602,50613,574
(Indirect)
View
2019-07-01
Purchase
2019-07-01
7:19 pm
Morphic Holding Inc.MORFNashat Amir
Director
125,000$15$1,875,000151,879
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-09
Other
2024-05-13
4:17 pm
N/A
N/A
Scholar Rock Holding CorpSRRKNashat Amir
Director
611,988$0749,160
(Indirect)
View
2023-12-27
Gift
2023-12-29
4:40 pm
N/A
N/A
Scholar Rock Holding CorpSRRKNashat Amir
Director
21,333$02,274,080
(Direct)
View
2023-12-13
Other
2023-12-15
4:26 pm
N/A
N/A
Scholar Rock Holding CorpSRRKNashat Amir
Director
1,223,976$01,467,883
(Indirect)
View
2023-11-20
Other
2023-11-22
4:30 pm
N/A
N/A
Scholar Rock Holding CorpSRRKNashat Amir
Director
611,992$0731,103
(Indirect)
View
2023-06-28
Other
2023-06-30
7:12 pm
N/A
N/A
Morphic Holding Inc.MORFNashat Amir
Director
101,080$0232,313
(Indirect)
View
2023-06-21
Option Award
2023-06-22
7:20 pm
N/A
2033-06-21
Scholar Rock Holding CorpSRRKNashat Amir
Director
36,000$036,000
(Direct)
View
2023-06-01
Option Award
2023-06-02
7:04 pm
N/A
2033-05-31
Morphic Holding Inc.MORFNashat Amir
Director
12,535$012,535
(Direct)
View
2022-05-18
Option Award
2022-09-06
7:27 pm
N/A
2032-05-17
Metacrine Inc.MTCRNashat Amir
Director
10% Owner
16,500$016,500
(Direct)
View
2022-06-08
Option Award
2022-06-10
7:00 pm
N/A
2032-06-07
Morphic Holding Inc.MORFNashat Amir
Director
17,550$017,550
(Direct)
View
2022-06-01
Option Award
2022-06-02
7:08 pm
N/A
2032-05-31
Syros Pharmaceuticals Inc.SYRSNashat Amir
Director
17,500$017,500
(Direct)
View
2022-05-26
Option Award
2022-05-27
4:34 pm
N/A
2032-05-26
Scholar Rock Holding CorpSRRKNashat Amir
Director
28,000$028,000
(Direct)
View
2021-06-16
Option Award(A)
2022-04-29
4:17 pm
N/A
2031-06-16
Morphic Holding Inc.MORFNashat Amir
Director
9,910$09,910
(Direct)
View
2021-11-17
Other
2021-11-19
4:32 pm
N/A
N/A
Scholar Rock Holding CorpSRRKNashat Amir
Director
346,721$0409,989
(Indirect)
View
2021-06-16
Option Award
2021-06-17
7:12 pm
N/A
2031-06-16
Morphic Holding Inc.MORFNashat Amir
Director
12,000$012,000
(Direct)
View
2021-06-08
Option Award
2021-06-10
5:29 pm
N/A
2031-06-07
Syros Pharmaceuticals Inc.SYRSNashat Amir
Director
17,500$017,500
(Direct)
View
2021-05-27
Option Award
2021-06-01
4:11 pm
N/A
2031-05-27
Scholar Rock Holding CorpSRRKNashat Amir
Director
7,800$07,800
(Direct)
View
2021-05-24
Option Award
2021-05-25
7:03 pm
N/A
2031-05-23
Metacrine Inc.MTCRNashat Amir
Director
10% Owner
16,500$016,500
(Direct)
View
2020-09-18
Conversion
2020-09-22
5:10 pm
N/A
N/A
Metacrine Inc.MTCRNashat Amir
Director
10% Owner
2,664,258$0178,942
(Indirect)
View

Ownership
2020-09-15
5:11 pm
N/A
N/A
Metacrine Inc.MTCRNashat Amir
Director
10% Owner
0$02,664,258
(Indirect)
View
2020-06-18
Option Award
2020-06-19
6:20 pm
N/A
2030-06-18
Morphic Holding Inc.MORFNashat Amir
Director
12,000$012,000
(Direct)
View
2020-06-16
Option Award
2020-06-18
4:24 pm
N/A
2030-06-16
Scholar Rock Holding CorpSRRKNashat Amir
Director
10% Owner
13,000$013,000
(Direct)
View
2020-06-11
Option Award
2020-06-11
4:52 pm
N/A
2030-06-10
Syros Pharmaceuticals Inc.SYRSNashat Amir
Director
17,500$017,500
(Direct)
View
2019-07-01
Conversion
2019-07-01
7:19 pm
N/A
N/A
Morphic Holding Inc.MORFNashat Amir
Director
2,197,946$0151,879
(Indirect)
View

Ownership
2019-06-26
9:25 pm
N/A
N/A
Morphic Holding Inc.MORFNashat Amir
Director
0$02,221,946
(Direct)
View
2019-06-14
Option Award
2019-06-18
4:21 pm
N/A
2029-06-13
SELECTA BIOSCIENCES INCSELBNashat Amir
Director
10,000$010,000
(Direct)
View
2019-06-11
Option Award
2019-06-12
4:15 pm
N/A
2029-06-10
Syros Pharmaceuticals Inc.SYRSNashat Amir
Director
11,000$011,000
(Direct)
View
(A) Indicate amendment filing.